查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1832465

2025-2032 年全球基因改造作物農業生物技術市場預測（按性狀類型、作物類型、應用和最終用戶分類）

Agricultural Biotechnology for Transgenic Crops Market by Trait Type, Crop Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，基改作物的農業生技市場規模將成長至 337 億美元，複合年成長率為 19.14%。

主要市場統計數據
基準年2024年 82.9億美元
預計2025年 98.9億美元
預測年份：2032年 337億美元
複合年成長率（%） 19.14%

在技​​術進步、監管變化和整個農業價值鏈相關人員的期望下，制定生物技術作物部署的戰略背景

隨著基改作物從利基創新領域逐漸發展成為具有韌性的農業糧食系統的核心組成部分，農業生物技術領域正在經歷關鍵性的變革。性狀工程的發展，加上法律規範的演變和貿易動態的變化，正在重塑從種子開發者到農民再到政策制定者等相關人員對作物改良的處理方式。本引言概述了影響基改作物發展的多維力量，並將後續分析置於研究流程、供應鏈整合和市場發展的現實背景中。

過去十年，精準育種技術和改良的性狀疊加技術提升了針對耐旱性、耐除草劑性和抗蟲性的基因改造解決方案的技術可行性和商業性吸引力。同時，終端用戶對穩定產量、降低投入成本和降低環境風險的需求，使得人們更加關注那些能夠帶來明顯農藝和經濟效益的性狀。因此，價值鏈上的組織正在重新調整其優先事項，並將研發投資與已在田間驗證的性狀結合。

本報告首先概述了基因改造作物推廣的策略背景及其對關鍵相關人員的營運影響。透過綜合科學趨勢、監管訊號和市場行為，本引言將幫助讀者理解後續的深入分析，並確定投資和政策選擇最關鍵的策略曲折點。

快速的技術創新、不斷發展的法律規範和不斷變化的商業性重點如何重新定義基改作物開發的價值創造和競爭定位

基因改造作物格局正在發生變化，改變了競爭格局、投資重點和應用途徑。基因編輯、性狀疊加和高通量表現型分析技術的進步正在加速可操作性狀從概念到田間試驗的轉化。因此，那些將分子創新與實用育種策略和可靠的田間檢驗相結合的公司正在獲得戰略優勢。這種技術動能與種苗公司營運的成熟度相得益彰，他們將獨特性狀與強化種子處理和數位農學相結合，為農場帶來顯著的價值。

同時，法律規範也不斷發展，以適應新型生物技術的發展，同時兼顧大眾接受度和生物安全問題。一些司法管轄區簡化了某些基因編輯計畫的核准流程，加快了其商業化進程，促使全球重新思考發展策略。即便如此，監管多樣性依然存在，企業必須設計出合規且足夠靈活的產品系列，以滿足各主要市場不同的核准要求。

隨著下游相關人員（例如加工商、食品和飼料公司以及農民）評估基因改造技術的經濟和永續性影響，市場接受度也在改變。人們對抗逆力的日益關注，使得耐旱性等特性的重要性日益凸顯，而病蟲害綜合治理的優先性則繼續支撐著抗蟲創新。總而言之，這些轉型變革正在重新定義基因改造生態系統中價值創造和取得的領域，凸顯了跨職能策略的必要性，該策略將科學、監管事務和商業性執行融為一體。

了解2025年關稅政策變化對基改作物供應鏈研究合作和農場決策的更廣泛的商業性和管理影響

2025年之前宣布並實施的關稅政策變化的累積效應，帶來了供應商和買家無法忽視的商業性複雜性。關稅調整會影響整個國際供應鏈中交易農產品、種子投入和性狀的成本計算。對於跨國開發商而言，關稅波動使生產階段、田間試驗和庫存位置的決策變得複雜，從而影響到在以出口為重點的作物領域保持競爭力所必需的定價策略。

貿易緊張局勢也對研發合作產生間接影響。當種質資源、生物材料和專用設備的跨境交換變得更加昂貴或行政負擔加重時，計劃週期就會延長，貿易摩擦也會加劇。在此背景下，企業正在重新調整夥伴關係模式，優先選擇區域育種和規模化生產中心，以降低關稅帶來的成本衝擊，同時維持對重要種質資源庫的取得。

從農民和加工商的角度來看，關稅導致的投入和商品經濟變化可能會改變作物輪作和管理選擇，從而影響基因改造需求。例如，玉米、大豆、棉花和油菜籽進出口獎勵的變化可能會改變生產者的風險回報計算，並加速或延緩某些基因改造特性的採用。因此，政策制定者和產業領導者必須考慮關稅的直接影響，以及可能再形成全部區域基因改造採用模式的一系列行為反應。

利用細緻的轉化作物應用和最終用戶細分，使研究重點與商業化策略和相關人員參與基因改造作物舉措保持一致

有效的細分主導方法可以揭示技術進步和商業性需求的交匯點，從而創造差異化機會。基於性狀類型，耐旱性、耐除草劑性和抗蟲性被強調為近期採用的關鍵載體，每種性狀都具有獨特的農藝效益並影響育種重點。基於作物類型，油菜、棉花、玉米和大豆表現出作物特異性途徑，具有顯著不同的性狀價值提案、調控途徑和種子系統動態。基於最終用途，生質燃料、食品和飼料、藥品和加工應用定義了最終市場要求和品質閾值，從而決定了性狀選擇、管理期望和可追溯性需求。基於最終用戶，生態系統由生物技術公司、企業概況、政府機構、研究機構和種苗公司組成，每家公司都對商業化時間表、責任概況和採用獎勵施加獨特的壓力。

從策略角度解讀市場細分，我們發現以性狀為中心的投資必須與作物經濟效益和應用需求緊密結合。由於氣候變遷威脅產量穩定性，抗旱性具有重要的戰略意義，而除草劑抗性和抗蟲性則繼續支持營運效率和病蟲害管理策略。由於作物本身的限制和加工要求，千篇一律的性狀開發方法不太可能帶來永續的效益。相反，將性狀創新與種子性能、管理框架和供應鏈保障相結合的綜合項目更有可能實現更廣泛的應用。

此外，終端用戶的多樣性凸顯了跨部門合作的必要性。成功的應用取決於能否讓農民參與檢驗在現實環境中的農藝效益，與種苗公司協調分銷和管理，與研究機構合作進行長期性狀改良，以及與政府機構合作以確保監管協調和公眾信任。基於此類細分層次洞察，制定研發和商業化規劃，可以幫助組織更好地分配資源，並針對對應用至關重要的相關人員訂做訊息。

了解美洲、歐洲、中東和非洲以及亞太地區的商業機會和監管現實，以最佳化性狀開發和打入市場策略

區域動態在塑造基因改造作物推廣軌跡和產業參與者的管理選擇方面發揮著至關重要的作用。美洲擁有一體化的價值鏈、強大的私營育種能力以及對基因改造技術的廣泛農場，為快速迭代和商業性規模化提供了有利條件。這種環境支持進行性狀組合實驗，並允許商業營業單位在不同農業生態學區域檢驗農藝性狀。

歐洲、中東和非洲：歐洲、中東和非洲的監管和社會環境更為複雜，公眾認知、多樣化的監管方式以及參差不齊的基礎架構層，使得制定差異化戰略成為可能。在該地區的一些司法管轄區，嚴格的監管要求和日益嚴格的相關人員審查，使得採取審慎的、注重透明度的策略成為必要。同時，非洲和中東部分地區為開發商提供了戰略機遇，使他們能夠利用自身特質，應對氣候變遷並解決資源限制問題，前提是他們能夠投資於公眾參與和能力建設。

亞太地區提供了廣泛的應用場景，從高度商業化的種植系統到以小農戶為主的種植模式。法規環境和消費者偏好差異巨大，影響產品的接受度、管理模式和夥伴關係結構。在該地區經營的私人公司擴大尋求本地化的育種計畫和官民合作關係，以確保基因改造性狀既能滿足大規模的商品需求，又能應對本地化的作物挑戰。任何地區的成功都取決於根據當地監管現狀、供應鏈結構和相關人員的期望制定合適的策略。

檢驗綜合研發夥伴關係夥伴關係和卓越營運如何決定基因改造作物開發生態系統中的競爭優勢

基因改造作物領域的競爭力取決於科學研究能力、監管專業知識和商業性可行性的結合。領先的機構透過管理整個創新生命週期（從發現和分子表徵，到多地點田間檢驗、監管申報和商業性種子繁殖）來脫穎而出。夥伴關係、授權協議和收購仍然是擴大性狀組合和加快上市時間的重要槓桿。

成功的公司在專有性狀開發、管理和供應鏈完整性方面展現出實力。這些公司投資於數據主導的農藝服務、農民培訓計畫和轉化後監測，以保持轉化效果並管理抗性風險。將分子研發與實踐推廣和商業性支援相結合的公司，更有能力實現持續應用，並降低聲譽和監管風險。

研究機構和公共部門參與者將繼續發揮關鍵作用，尤其是在早期發現以及優先考慮公共產品（例如小農農業系統的抗旱能力）的情況下。將私部門的規模與公共部門的合法性結合的合作模式，可以加速科技的應用，同時解決社會關切。整體而言，競爭格局有利於垂直整合能力、協作敏捷性以及嚴謹的監管和管理義務履行方式。

採取策略行動，同步性狀開發監管準備、供應鏈彈性和管理工作，確保負責任且可擴展地部署生物技術作物。

產業領導者應採取一系列切實可行的行動，將科學前景轉化為商業性韌性和社會價值。首先，應將性狀開發藍圖與作物特定的農藝現實和終端市場需求相結合，優先考慮那些在氣候變遷下能夠帶來可衡量的農場效益和韌性的性狀。其次，應透過投資模組化資料包、靈活的試驗設計以及積極與監管機構和民間社會相關人員互動，制定能夠預測不同司法管轄區差異的監管策略。

第三，我們將透過建立區域育種中心、區域種子繁殖能力和冗餘物流來增強供應鏈的韌性，以緩解關稅和貿易中斷。第四，我們將致力於實施強力的管理項目，將抗藥性管理、農民培訓和上市後監測相結合，以維護性狀效力和公眾信任。第五，我們將推行共同研究模式，將公共研究優勢與私部門商業化能力結合，以因應小農戶面臨的挑戰並提升社會合法性。

最後，投資透明的傳播策略，清楚闡明基因改造解決方案的農藝、環境和經濟原理，同時公開討論安全和管理問題。透過協同實施這些行動，領導者可以減少商業化摩擦，在適當的情況下促進採用，並使基改作物創新與更廣泛的永續性和糧食安全目標保持一致。

調查方法整合了主要專家訪談、二手文獻監管審查和價值鏈分析，以確保得出嚴謹、基於證據的結論

本研究整合了同行評審的科學文獻、監管文件、公共文件以及與專家相關人員的初步定性訪談，以建立堅實可靠的分析基礎。調查方法強調跨多個資料來源的三角測量，並透過專家諮詢進行檢驗，以確保解讀既能反映技術現狀，又能應對商業性限制。研究還審查了實地試驗報告、專利態勢和科學會議披露的資訊，以評估關鍵性狀類別的成熟度並識別新興技術能力。

初步研究包括對高級研發領導、監管專家、種苗公司高管和學術研究人員的結構化訪談，以了解關於採用障礙、管理實踐以及對貿易動態的戰略響應的不同觀點。二次研究涵蓋監管溝通、產業協會聲明以及廣泛接受的科學綜合，以鞏固初步研究結果。本研究採用的分析框架，包括價值鏈圖譜繪製、相關人員分析和基於情境的影響分析，探討了關稅變化和區域監管差異等變數如何影響策略選擇。

在整個調查方法中，我們非常重視方法的透明度，並記錄了定性推論所依據的假設。對於仍存在不確定性的情況，分析強調考慮突發事件，並建議進行有針對性的後續研究，以加深對基因編輯政策和跨國種質流動等快速發展領域的理解。

關於將科學創新與監管管理和相關人員參與相結合以負責任地發揮基因改造作物潛力的結論摘要

摘要，基改作物技術正處於一個策略曲折點，科學能力、不斷發展的法規和商業性需求在此交會。未來的發展需要整合策略，將轉化與作物的具體情況、應用需求和最終用戶的期望結合。雖然技術進步降低了寶貴性狀開發的技術壁壘，但監管制度的差異性和近期貿易政策的變化使營運環境更加複雜，需要製定適應性的商業化藍圖。

成功的組織將卓越的科學技術與切合實際的監管規劃、富有彈性的供應鏈設計和透明的管理相結合。跨部門合作對於解決社會關切、加速適應性育種以應對氣候變遷壓力以及確保多樣化農業系統受益仍然至關重要。最終，基改作物負責任的推廣取決於將創新與明確的農藝價值、監管合規性和相關人員的信任相結合，從而確保這些技術能夠對永續農業成果做出有意義的貢獻。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合RNA干擾技術進行棉花害蟲標靶防治
  • 採用具有多重抗性特徵的耐除草劑大豆品系進行雜草管理。
  • 富含維生素原A的生物強化稻米品種的商業化，以對抗營養不良
  • 基因驅動系統在主要作物入侵蟲族群控制的應用
  • 引入Glyphosate和草銨膦雙重抗性的菜籽品係以提高產量穩定性
  • 引進次世代定序，用於新型基改作物的監管核准

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 農業生物技術市場（基因改造作物類型）

  • 耐旱性
  • 除草劑抗性
  • 抗蟲性

9. 農業生物技術市場（基因改造作物，依作物類型）

  • 菜籽
  • 棉布
  • 玉米
  • 大豆

10. 農業生物技術市場（基因改造作物，依應用）

  • 生質燃料
  • 食品和飼料
  • 製藥
  • 流程

11. 農業生物技術市場（基因改造作物）的最終用戶

  • 生技公司
  • 農民
  • 政府機構
  • 研究機構
  • 種子公司

12. 農業生物技術市場（基因改造作物）地區作物

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

13. 農業生物技術市場（基因改造作物）依類別

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國基改作物農業生物技術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Bayer AG
    • Corteva, Inc.
    • Syngenta AG
    • BASF SE
    • KWS SAAT SE & Co. KGaA
    • Groupe Limagrain
    • Land O'Lakes, Inc.
    • Bioceres Crop Solutions Corp
    • Arcadia Biosciences, Inc.
    • Evogene Ltd
Product Code: MRR-433AB1DC2851

The Agricultural Biotechnology for Transgenic Crops Market is projected to grow by USD 33.70 billion at a CAGR of 19.14% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 8.29 billion
Estimated Year [2025] USD 9.89 billion
Forecast Year [2032] USD 33.70 billion
CAGR (%) 19.14%

Framing the strategic context for transgenic crop deployment amid technological advances regulatory shifts and stakeholder expectations across agricultural value chains

The agricultural biotechnology landscape is undergoing a pivotal transformation as transgenic crops move from niche innovations to core components of resilient agrifood systems. Advances in trait engineering, combined with evolving regulatory frameworks and shifting trade dynamics, are reshaping how stakeholders - from seed developers to farmers and policy makers - approach crop improvement. This introduction frames the multidimensional forces influencing transgenic crop development, situating the subsequent analysis within the practical realities of research pipelines, supply chain integration, and market acceptance.

Over the past decade, precision breeding techniques and improved trait stacking have increased both the technical feasibility and the commercial attractiveness of transgenic solutions targeting drought tolerance, herbicide tolerance, and insect resistance. At the same time, end-user demands for stable yields, reduced input costs, and environmental risk mitigation have sharpened the focus on traits that deliver clear agronomic and economic benefits. Consequently, organizations across the value chain are recalibrating priorities, aligning R&D investments with traits that demonstrate field-proven outcomes.

This report opens by outlining the strategic context for transgenic crop deployment and the operational implications for key stakeholders. By synthesizing scientific trends, regulatory signals, and market behaviors, the introduction prepares readers to interpret the deeper analyses that follow and to identify strategic inflection points where investment and policy choices will matter most.

How rapid technological innovation evolving regulatory frameworks and shifting commercial priorities are redefining value creation and competitive positioning in transgenic crop development

The landscape for transgenic crops is shifting in ways that alter competitive dynamics, investment priorities, and adoption pathways. Technological progress in gene editing, trait stacking, and high-throughput phenotyping has accelerated the pace at which actionable traits move from concept to field trials. As a result, companies that integrate molecular innovation with pragmatic breeding strategies and robust field validation are gaining a strategic edge. This technological momentum is complemented by growing operational sophistication among seed companies, which are increasingly combining proprietary traits with enhanced seed treatments and digital agronomy to deliver demonstrable on-farm value.

Simultaneously, regulatory frameworks are evolving to accommodate novel biotechnologies while balancing public acceptance and biosafety concerns. In several jurisdictions, streamlined approval pathways for certain gene-edited events have reduced time to commercialization, prompting a reconsideration of global development strategies. That said, regulatory heterogeneity persists, and firms must design compliant, flexible product portfolios that address divergent approval requirements across key markets.

Market acceptance is also changing as downstream actors-processors, food and feed companies, and farmers-assess the economic and sustainability implications of transgenic adoption. Increasing emphasis on resilience has elevated the importance of traits like drought tolerance, while integrated pest management priorities continue to support insect resistance innovations. Taken together, these transformative shifts are redefining where value is created and captured within the transgenic ecosystem, underscoring the need for cross-functional strategies that bridge science, regulatory affairs, and commercial execution.

Understanding the broad commercial and operational ripple effects of tariff policy changes on transgenic crop supply chains research collaborations and on-farm decision making through 2025

The cumulative effect of tariff policy changes announced and implemented through 2025 has introduced a layer of commercial complexity that suppliers and buyers cannot ignore. Tariff adjustments influence the cost calculus for traded agricultural commodities, seed inputs, and trait licensing across international supply chains. For multinational developers, tariff volatility complicates decisions about where to stage production, conduct field trials, and place inventory, and it affects the pricing strategies necessary to maintain competitiveness in export-focused crop segments.

Trade frictions also have indirect consequences for research and development collaborations. When cross-border exchanges of germplasm, biological materials, or specialized equipment become more expensive or administratively burdensome, project timelines extend and transactional friction increases. In that context, companies are recalibrating partnership models by emphasizing regional hubs for breeding and scaling operations, thereby reducing exposure to tariff-driven cost shocks while preserving access to critical germplasm pools.

From a farmer and processor perspective, tariff-driven changes to input and commodity economics can shift crop rotations and management choices, thereby influencing trait demand. For example, altered import or export incentives for maize, soybean, cotton, or canola change growers' risk-reward calculations and can accelerate or delay adoption of specific transgenic traits. Policymakers and industry leaders must therefore account for both direct tariff impacts and the cascade of behavioral responses that reshape deployment patterns across geographies.

Leveraging nuanced trait crop application and end user segmentation to align research priorities commercialization strategies and stakeholder engagement for transgenic crop initiatives

An effective segmentation-driven approach illuminates where technological advances and commercial demand intersect to create differentiated opportunities. Based on Trait Type, attention centers on Drought Tolerance, Herbicide Tolerance, and Insect Resistance as primary vectors for near-term adoption, each delivering distinct agronomic benefits and influencing breeding priorities. Based on Crop Type, Canola, Cotton, Maize, and Soybean represent crop-specific pathways where trait value propositions, regulatory pathways, and seed system dynamics vary markedly; strategic plans must reflect those crop-specific realities. Based on Application, Biofuel, Food & Feed, Pharmaceutical, and Processing uses define end-market requirements and quality thresholds that shape trait selection, stewardship expectations, and traceability needs. Based on End User, the ecosystem comprises Biotech Companies, Farmers, Government Bodies, Research Institutions, and Seed Companies, each of which exerts unique pressures on commercialization timelines, liability profiles, and adoption incentives.

Interpreting segmentation through a strategic lens reveals that trait-centric investment should align closely with crop economics and application needs. Drought tolerance commands strategic importance where climate variability threatens yield stability, while herbicide tolerance and insect resistance continue to underpin operational efficiencies and pest management strategies. Crop-specific constraints and processing requirements mean that a one-size-fits-all approach to trait development is unlikely to produce sustainable returns. Instead, integrated programs that couple trait innovation with seed performance, stewardship frameworks, and supply chain assurances will unlock broader acceptance.

Moreover, end-user diversity underscores the necessity of cross-sector engagement. Successful deployment depends on engaging farmers to validate agronomic benefits in real-world settings, coordinating with seed companies on distribution and stewardship, partnering with research institutions on long-term trait improvement, and working with government bodies to ensure regulatory alignment and public confidence. By grounding R&D and commercialization plans in these layered segmentation insights, organizations can better allocate resources and tailor messages to the stakeholders most critical to adoption.

Navigating distinct regional opportunities and regulatory realities across the Americas Europe Middle East & Africa and Asia-Pacific to optimize trait development and market entry strategies

Regional dynamics play a decisive role in shaping the trajectory of transgenic crop deployment and the operational choices of industry participants. In the Americas, integrated value chains, significant private-sector breeding capacity, and widespread farmer familiarity with transgenic technologies create fertile conditions for rapid iteration and commercial scaling. This environment supports experimentation with trait stacks and enables commercial entities to validate agronomic claims across diverse agroecological zones.

Europe, Middle East & Africa present a more complex regulatory and social landscape where public perception, diverse regulatory approaches, and heterogeneous infrastructure levels drive differentiated strategies. In some jurisdictions within this region, stringent regulatory requirements and heightened stakeholder scrutiny necessitate a cautious, transparency-focused approach. Meanwhile, parts of Africa and the Middle East represent strategic opportunities for traits that address climate resilience and resource constraints, provided developers invest in public engagement and capacity building.

Asia-Pacific encompasses a broad spectrum of adoption scenarios, from highly commercialized cropping systems to smallholder-dominated landscapes. Regulatory environments and consumer preferences vary widely, influencing product acceptance, stewardship models, and partnership structures. Companies operating in this region increasingly pursue localized breeding programs and public-private partnerships to ensure that transgenic traits address both large-scale commodity demands and localized crop challenges. Across all regions, success depends on tailoring strategies to regulatory realities, supply chain structures, and stakeholder expectations in each geography.

Examining how integrated R&D stewardship partnerships and operational excellence determine competitive advantage in the transgenic crop development ecosystem

Competitive dynamics within the transgenic crop arena are driven by a combination of scientific capability, regulatory expertise, and commercial execution. Leading organizations differentiate themselves by managing the entire innovation lifecycle: from discovery and molecular characterization to multi-location field validation, regulatory submission, and commercial seed multiplication. Partnerships, licensing arrangements, and acquisitions remain important levers for expanding trait portfolios and accelerating time-to-market.

In addition to proprietary trait development, successful companies demonstrate strength in stewardship and supply chain reliability. They invest in data-driven agronomy services, farmer training programs, and post-commercialization monitoring to preserve trait efficacy and manage resistance risks. Firms that integrate molecular R&D with practical extension and commercial support are better positioned to achieve durable adoption and mitigate reputational and regulatory risks.

Research institutions and public sector actors continue to play a critical role, particularly in early-stage discovery and in contexts where public goods such as drought tolerance for smallholder systems are prioritized. Collaborative models that combine private-sector scale with public-sector legitimacy can accelerate adoption while addressing societal concerns. Overall, the competitive landscape rewards vertically integrated capabilities, collaborative agility, and a disciplined approach to regulatory and stewardship obligations.

Mandated strategic actions to synchronize trait development regulatory preparedness supply chain resilience and stewardship efforts for scalable responsible adoption of transgenic crops

Industry leaders should adopt a set of practical actions to translate scientific promise into commercial resilience and societal value. First, align trait development roadmaps with crop-specific agronomic realities and end-market requirements, prioritizing traits that deliver measurable on-farm benefits and resilience under climate variability. Second, build regulatory strategies that anticipate heterogeneity across jurisdictions by investing in modular data packages, adaptive trial designs, and proactive engagement with regulators and civil society stakeholders.

Third, strengthen supply chain resilience by establishing regional breeding hubs, local seed multiplication capacity, and redundant logistics to mitigate tariff or trade disruptions. Fourth, commit to robust stewardship programs that combine resistance management, farmer training, and post-market surveillance to maintain trait efficacy and public trust. Fifth, pursue collaborative models that leverage public research strengths alongside private-sector commercialization capacity to address challenges in smallholder contexts and to broaden social legitimacy.

Finally, invest in transparent communication strategies that articulate the agronomic, environmental, and economic rationale for transgenic solutions while openly addressing safety and stewardship concerns. By executing these actions in concert, leaders can reduce commercialization friction, accelerate adoption where appropriate, and align transgenic crop innovations with broader sustainability and food security goals.

Methodological approach that integrates primary expert interviews secondary literature regulatory review and value chain analysis to ensure rigorous evidence-based conclusions

This research synthesizes peer-reviewed scientific literature, regulatory filings, public policy documents, and primary qualitative interviews with expert stakeholders to construct a robust and defensible analytical foundation. The methodology emphasizes triangulation across multiple data sources and validation through expert consultation to ensure that interpretations reflect both technological realities and commercial constraints. Field trial reports, patent landscapes, and scientific conference disclosures were reviewed to assess the maturity of key trait categories and to identify emergent technical capabilities.

Primary research included structured interviews with senior R&D leaders, regulatory specialists, seed company executives, and academic researchers to capture diverse perspectives on adoption barriers, stewardship practices, and strategic responses to trade dynamics. Secondary research encompassed regulatory agency communications, industry association statements, and widely accepted scientific syntheses to contextualize primary findings. Analytical frameworks applied in the study include value chain mapping, stakeholder analysis, and scenario-based impact assessment to explore how variables such as tariff shifts and regional regulatory divergence influence strategic choices.

Throughout the research process, attention was paid to methodological transparency and to documenting assumptions that underpin qualitative inferences. Where uncertainty persists, the analysis highlights contingency considerations and recommends targeted follow-up studies to refine understanding in rapidly evolving areas such as gene-editing policy and cross-border germplasm flows.

Concluding synthesis on aligning scientific innovation regulatory compliance stewardship and stakeholder engagement to realize the potential of transgenic crops responsibly

In summary, transgenic crop technologies stand at a strategic inflection point where scientific capability, regulatory evolution, and commercial imperatives converge. The path forward requires integrated strategies that link trait innovation to crop-specific realities, application demands, and end-user expectations. While technological progress lowers technical barriers to developing valuable traits, heterogeneity in regulatory regimes and recent trade policy shifts complicate the operational landscape and necessitate adaptive commercialization roadmaps.

Organizations that succeed will combine scientific excellence with pragmatic regulatory planning, resilient supply chain design, and transparent stewardship. Cross-sector collaboration remains essential for addressing societal concerns, accelerating adaptive breeding in response to climate pressures, and ensuring that benefits reach diverse farming systems. Ultimately, the responsible advancement of transgenic crops hinges on aligning innovation with clear agronomic value, regulatory compliance, and stakeholder trust, thereby enabling these technologies to contribute meaningfully to sustainable agricultural outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of RNA interference techniques for targeted insect pest suppression in cotton
  • 5.2. Adoption of herbicide tolerant soybean lines with stacked tolerance traits for weed management
  • 5.3. Commercialization of biofortified rice varieties enriched with provitamin A to address malnutrition
  • 5.4. Application of gene drive systems to control invasive pest populations in staple crops
  • 5.5. Deployment of glyphosate and glufosinate dual-tolerant canola lines to improve yield stability
  • 5.6. Implementation of next generation sequencing for regulatory approval of novel transgenic crops

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Agricultural Biotechnology for Transgenic Crops Market, by Trait Type

  • 8.1. Drought Tolerance
  • 8.2. Herbicide Tolerance
  • 8.3. Insect Resistance

9. Agricultural Biotechnology for Transgenic Crops Market, by Crop Type

  • 9.1. Canola
  • 9.2. Cotton
  • 9.3. Maize
  • 9.4. Soybean

10. Agricultural Biotechnology for Transgenic Crops Market, by Application

  • 10.1. Biofuel
  • 10.2. Food & Feed
  • 10.3. Pharmaceutical
  • 10.4. Processing

11. Agricultural Biotechnology for Transgenic Crops Market, by End User

  • 11.1. Biotech Companies
  • 11.2. Farmers
  • 11.3. Government Bodies
  • 11.4. Research Institutions
  • 11.5. Seed Companies

12. Agricultural Biotechnology for Transgenic Crops Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Agricultural Biotechnology for Transgenic Crops Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Agricultural Biotechnology for Transgenic Crops Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Bayer AG
    • 15.3.2. Corteva, Inc.
    • 15.3.3. Syngenta AG
    • 15.3.4. BASF SE
    • 15.3.5. KWS SAAT SE & Co. KGaA
    • 15.3.6. Groupe Limagrain
    • 15.3.7. Land O'Lakes, Inc.
    • 15.3.8. Bioceres Crop Solutions Corp
    • 15.3.9. Arcadia Biosciences, Inc.
    • 15.3.10. Evogene Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY DROUGHT TOLERANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY HERBICIDE TOLERANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY INSECT RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CANOLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COTTON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY MAIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOFUEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FOOD & FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY FARMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GOVERNMENT BODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ASEAN AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. GCC AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPEAN UNION AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. BRICS AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. G7 AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. NATO AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED STATES AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. CANADA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. CANADA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY TRAIT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. CANADA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. CANADA AGRICULTURAL BIOTECHNOLOGY FOR TRANSGENIC CROPS MARKET SIZE, BY CROP TYPE, 2025-2032 (U